Previous 10 |
ROCKVILLE, Md., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN) today announced that it intends to offer and sell shares of its common stock and warrants to purchase shares of its common stock in an underwritten public offering. The offering is subject to...
Gainers: Luokung Technology (NASDAQ: LKCO ) +136% . UQM Technologies (NYSEMKT: UQM ) +46% . Staffing 360 Solutions (NASDAQ: STAF ) +24% . MYnd Analytics (NASDAQ: MYND ) +18% . Boxlight Corporation (NASDAQ: BOXL ) +15% . XTL Biopharmaceuticals (NASDAQ: XTLB ) +14% . M...
ROCKVILLE, Md., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical-stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that are difficult to treat, presented updated, preliminary data from the on...
News, Short Squeeze, Breakout and More Instantly...
Rexahn Pharmaceuticals Inc. Company Name:
RNN Stock Symbol:
NYSE Market:
Rexahn Pharmaceuticals Inc. Website:
ROCKVILLE, Md., May 28, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that are difficult to treat, today announced that it will voluntarily transfe...
ROCKVILLE, Md., May 13, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that are difficult to treat, today announced financial results for the first ...
ROCKVILLE, Md. and SUZHOU, China, April 16, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage, biopharmaceutical company focused on oncology, and BioSense Global LLC, a New Jersey- and Suzhou, China-based biopharmaceutical company, today announced ...